Roche has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). Roche ranked third, Chugai Pharmaceuticals, a member of the Roche Group, ranked second. “We are extremely proud…
Pfizer today announced the successful completion of its acquisition of Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share,…
For the second year running, Servier has awarded the Servier Discovery Award to a Californian life sciences start-up. For the 2023 edition, Palm Therapeutics was rewarded for its innovative platform and approach in precision oncology drug development. Servier takes an…
AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines using an innovative, protein virus-like particle (VLP) platform. The proposed acquisition will build on AstraZeneca’s expertise in respiratory…
Ashley Magargee has been appointed to the role of Chief Executive Officer of Genentech, a member of the Roche Group, effective January 1, 2024. In addition to her role as Head of US Commercial Portfolio, Magargee has been serving as…
AbbVie and Cerevel Therapeutics announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline of multiple clinical-stage and preclinical candidates with potential across several diseases including schizophrenia, Parkinson’s disease (PD), and mood disorders. The…
Merck Group today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integration. It combines generative AI, machine learning and…
Servier wins the Digital Transformation prize at the BFM Awards. The 19th edition of the BFM Awards, the flagship event of the French television channel BFM Business in the presence of over 500 decision-makers from France’s biggest companies and start-ups.…
Takeda and The New York Academy of Sciences today announced the winners of the 2024 Innovators in Science Award for their excellence in, and commitment to, innovative science that has significantly advanced the field of research in cancer immunology. Each…
Servier announces the appointment of Nicolas Garnier as Chief Patient Officer, effective from December 4, 2023. He takes over from Bertrand Renaud, who will retire at the end of January 2024. Reporting to Arnaud Lallouette, Executive Vice President Global Medical…